Steris (STE): Bridgewater Associates reduced its stake -5,355 shares
Bridgewater Associates reduced its stake in Steris, per its Q4 2025 13F.
- 3,361
- Shares reported · -5,355 vs prior quarter
- 0.00%
- Disclosed portfolio weight
- $852K
- Reported value
- Holdings as of
- Dec 31, 2025
- Filed
- Feb 13, 2026
What stands out in this filing
- 8,716 shares in Q3 2025, 3,361 now (−61.4% in share count).
- 38 other tracked managers reported the same kind of change for Q4 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: reported its results, 9 days earlier (Feb 4, 2026). The first one after it: changed a top executive or board member, 46 days later (Mar 31, 2026).
- Company filing · Form 8-K · ResultsReported its results
- CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- CongressDisclosed purchase of STE — reported range $1,001 - $15,000
What came next
- InsiderDirector sold ~$735K of STE shares in the open market
- CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- 5% stakeThe Vanguard Group reported a passive stake (13G)
- Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 31, 2026, STERIS plc (the “Company”) and Michael J. Tokich, the Company’s former Chief Financial Officer, entered into an amendment (the “Amendment”) to the Transition Agreement, dated August 5, 2025, between the Company and Mr. Tokich (the “Agreement”).”
- FDAFDA device clearance: SYSTEM 1E Liquid Chemical Sterilant Processing System, Model P6700; SYSTEM 1 endo Liquid Chemical Sterilant Processing System, Model P6900
- FDAFDA device clearance: Celerity 5 HP Biological Indicator (LCB052)
- 5% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.0%
- CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- 5% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On May 1, 2026, Richard C. Breeden notified STERIS plc (the “Company”) that he will not stand for reelection to the Board of Directors (the “Board”) at the Company’s 2026 Annual General Meeting of Shareholders.”
- CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- Company filing · Form 8-K · ResultsReported its results
- Congress · 1 personMembers of Congress: 2 purchases
- 5% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.1%
- CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- FDARecall: HarmonyAIR A-Series Surgical Lighting System
- FDARecall: HarmonyAIR A-Series Surgical Lighting System
- FDARecall: ALYON Surgical Lighting System
- InsiderDirector sold ~$310K of STE shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Steris
For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STE page.
How this filing works
Explore the data
Common questions
What does this filing report about Steris (STE) stock?
Bridgewater Associates reduced its stake in Steris, per its Q4 2025 13F. Now 3,361 shares, $852K reported value, 0.00% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Dec 31, 2025. Filed: Feb 13, 2026.
What stands out in this filing?
8,716 shares in Q3 2025, 3,361 now (−61.4% in share count). 38 other tracked managers reported the same kind of change for Q4 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Steris recently?
For Steris, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 3 Congress trade reports dated in the last 90 days. They are listed on the STE page.
Does this mean STE stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Steris
- SEC Form 4Nov 17, 2026
- SEC Form 144Nov 13, 2026
- SEC Form 144Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 4Nov 12, 2026
Everything OQRO holds on this company is on its STE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
